Pharmastandort 2030
3 questions to our new board member: Julian Bertschinger, Head EMEA, External Scientific Innovation at Johnson & Johnson
3 questions to our new board member: Jérome Garcin, General Manager for Switzerland and Austria bei Bristol Myers Squibb
Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda
Three questions for the new Chair of the Market Committee: Myriam DeLeone, Managing Director of Amgen Switzerland
Three questions to our new board members: President Region Europe at Novartis und Vice President of the Interpharma Board
Three questions to our new board members: Florian Saur, Country General Manager Switzerland, AstraZeneca
Three questions to our new board members: Linn Mandahl, Vice President Europe Region South at AbbVie